OTCWagon Join The OtcWagon
  • Home
  • About Us
  • OTC
  • Pinks
  • NSDQ
  • NYSE
  • Contact Us

Featured Stocks

  • ImmunoPrecise Antibodies Ltd., ( OTCMKTS: IPATF )

    Get Quote

    ImmunoPrecise’s proprietary technologies and products are positioned on the leading edge of antibody development, innovating our industry as a single source provider of the full complement of antibody discovery platforms. As an investor in ImmunoPrecise Antibodies, you’re joining us at the forefront of new, exciting, and valuable advancements in next-generation antibody discovery.

    ImmunoPrecise Antibodies Ltd., ( OTCMKTS: IPATF )

    Get Quote

    ImmunoPrecise’s proprietary technologies and products are positioned on the leading edge of antibody development, innovating our industry as a single source provider of the full complement of antibody discovery platforms. As an investor in ImmunoPrecise Antibodies, you’re joining us at the forefront of new, exciting, and valuable advancements in next-generation antibody discovery.

  • Ascent Solar Technologies Inc, ( OTCMKTS:ASTI )

    Get Quote

    Ascent Solar Technologies, Inc. is engaged in commercializing flexible photovoltaic (PV) modules using its technology. The Company’s manufacturing process deposits multiple layers of materials, including a thin film of copper-indium-gallium-diselenide (CIGS) semiconductor material, on a plastic substrate using a roll-to-roll manufacturing process and then laser patterns the layers to create interconnected PV cells or PV modules, in a process known as monolithic integration. The Company is producing consumer oriented products focusing on charging devices powered by its solar modules. It manufactures its products by affixing a thin CIGS layer to a flexible, plastic substrate using a roll-to-roll process.

    Ascent Solar Technologies Inc, ( OTCMKTS:ASTI )

    Get Quote

    Ascent Solar Technologies, Inc. is engaged in commercializing flexible photovoltaic (PV) modules using its technology. The Company’s manufacturing process deposits multiple layers of materials, including a thin film of copper-indium-gallium-diselenide (CIGS) semiconductor material, on a plastic substrate using a roll-to-roll manufacturing process and then laser patterns the layers to create interconnected PV cells or PV modules, in a process known as monolithic integration. The Company is producing consumer oriented products focusing on charging devices powered by its solar modules. It manufactures its products by affixing a thin CIGS layer to a flexible, plastic substrate using a roll-to-roll process.

  • Canadian Zeolite Corp, ( TSXV:CNZ )

    Get Quote

    Canadian Zeolite Corp., formerly Canadian Mining Company Inc., is an exploration-stage company, which is engaged in the evaluation, acquisition, exploration, development and operation of mineral properties in British Columbia and Arizona, the United States. The Company’s property interest is its Bromley Creek Zeolite Project, which consists of a mineral lease and over six mineral claims. Its mineral claims include Bromley #4, Bromley #5, Bromley #6, Bromley #1, Bromley #2 and Bromley #3. The Company owns the Sun Group Zeolite Project located in the Similkameen Mining District of British Columbia. The total claim area is approximately 948.93 hectares. Its Sun Group Zeolite Project claims consist of ZEO-TECH 1, SUNDAY CREEK 1, SUNDAY CREEK 2, SUNDAY CREEK 3, SUNDAY CREEK 4, SUNDAY CREEK 5, SUNDAY CREEK 6, SUNDAY, ZEO-TECH 2 and ZEO-MAR 3. The Company’s mineral properties are in the exploration and development-stage. The Company has not generated revenue from operations.

    Canadian Zeolite Corp, ( TSXV:CNZ )

    Get Quote

    Canadian Zeolite Corp., formerly Canadian Mining Company Inc., is an exploration-stage company, which is engaged in the evaluation, acquisition, exploration, development and operation of mineral properties in British Columbia and Arizona, the United States. The Company’s property interest is its Bromley Creek Zeolite Project, which consists of a mineral lease and over six mineral claims. Its mineral claims include Bromley #4, Bromley #5, Bromley #6, Bromley #1, Bromley #2 and Bromley #3. The Company owns the Sun Group Zeolite Project located in the Similkameen Mining District of British Columbia. The total claim area is approximately 948.93 hectares. Its Sun Group Zeolite Project claims consist of ZEO-TECH 1, SUNDAY CREEK 1, SUNDAY CREEK 2, SUNDAY CREEK 3, SUNDAY CREEK 4, SUNDAY CREEK 5, SUNDAY CREEK 6, SUNDAY, ZEO-TECH 2 and ZEO-MAR 3. The Company’s mineral properties are in the exploration and development-stage. The Company has not generated revenue from operations.

  • Cytori Therapeutics Inc, ( NASDAQ:CYTX )

    Get Quote

    Cytori Therapeutics, Inc. (Cytori) is a biotechnology company involved in the development of treatments and devices for a range of disorders using cells as a key part of the therapy. The Company is engaged in developing primary product, Cytori Cell Therapy, for patients with scleroderma hand dysfunction, orthopedic disorders, cardiovascular disease, urinary incontinence and thermal burns combined with radiation injury. The Company commercializes the Celution System under select medical device approvals, clearances and registrations to research customers developing new therapeutic applications for Cytori Cell Therapy in Europe, Japan and other regions. The Company offers ECCO-50, a cure for knee osteoarthritis, which is in ECCO-50 Phase IIA/B of development. It offers ECCI-50, a cure for urinary incontinence, which is in Phase II/III of development. The Company is also developing DCCT-10, a cure for cutaneous thermal injury.

    Cytori Therapeutics Inc, ( NASDAQ:CYTX )

    Get Quote

    Cytori Therapeutics, Inc. (Cytori) is a biotechnology company involved in the development of treatments and devices for a range of disorders using cells as a key part of the therapy. The Company is engaged in developing primary product, Cytori Cell Therapy, for patients with scleroderma hand dysfunction, orthopedic disorders, cardiovascular disease, urinary incontinence and thermal burns combined with radiation injury. The Company commercializes the Celution System under select medical device approvals, clearances and registrations to research customers developing new therapeutic applications for Cytori Cell Therapy in Europe, Japan and other regions. The Company offers ECCO-50, a cure for knee osteoarthritis, which is in ECCO-50 Phase IIA/B of development. It offers ECCI-50, a cure for urinary incontinence, which is in Phase II/III of development. The Company is also developing DCCT-10, a cure for cutaneous thermal injury.

  • Dajin Resources Corp, ( TSX.V:DJI )

    Get Quote

    Dajin Resources Corp. is an energy metals company with brine based lithium exploration projects strategically located in both South and North America.

    The company holds a 100% interest in 294 placer claims totaling 2,369 hectares (5,853 acres) located on a desert playa known as Teels Marsh in Mineral County, Nevada. This is a potential brine-based lithium target. Exploration activities since early 2015 have included: a gravity survey, a 9-hole Geoprobe survey, a structural analysis and more recently, a seismic survey was carried out during May-June 2016. Most importantly, water rights have been granted to Dajin by the Nevada Division of Water Resources for the Teels Marsh. Permitting is in progress for drilling of four wells in early 2017.

    The company also holds 191 placer claims totaling 1,558 hectares (3,851 acres) in Alkali Lake, Esmeralda County, Nevada, just 12 km from Albemarle’s Rockwood Lithium Mine, North America’s only producing brine-based lithium mine.

    Dajin also holds the rights to a 100% interest in certain mineral concessions totalling 93,000 hectares (230,000 acres) in the salt lake basin known as Salinas Grandes in Jujuy Province, Argentina. These claims are located within the “Lithium Triangle” which is reported to contain in excess of 80% of the world’s supply of lithium. Dajin’s wholly owned Argentinian subsidiary, Dajin Resources S. A., has entered into an agreement with Lithium S Corporation (“Lithium S”) whereby Lithium S has been granted an option to earn a 51% interest in Dajin’s lithium properties in Argentina upon the payment of $1,000,000 (paid) and the expenditure of $2,000,000 on the property within 2 years from receipt of exploration permit.

    In addition, Lithium S has subscribed for 2,777,777 Units of Dajin Resources Corp. at $0.18 per unit with 2,777,777 non-transferable share purchase warrants attached exercisable at $0.25 per share within 2 years.

    Dajin Resources Corp, ( TSX.V:DJI )

    Get Quote

    Dajin Resources Corp. is an energy metals company with brine based lithium exploration projects strategically located in both South and North America.

    The company holds a 100% interest in 294 placer claims totaling 2,369 hectares (5,853 acres) located on a desert playa known as Teels Marsh in Mineral County, Nevada. This is a potential brine-based lithium target. Exploration activities since early 2015 have included: a gravity survey, a 9-hole Geoprobe survey, a structural analysis and more recently, a seismic survey was carried out during May-June 2016. Most importantly, water rights have been granted to Dajin by the Nevada Division of Water Resources for the Teels Marsh. Permitting is in progress for drilling of four wells in early 2017.

    The company also holds 191 placer claims totaling 1,558 hectares (3,851 acres) in Alkali Lake, Esmeralda County, Nevada, just 12 km from Albemarle’s Rockwood Lithium Mine, North America’s only producing brine-based lithium mine.

    Dajin also holds the rights to a 100% interest in certain mineral concessions totalling 93,000 hectares (230,000 acres) in the salt lake basin known as Salinas Grandes in Jujuy Province, Argentina. These claims are located within the “Lithium Triangle” which is reported to contain in excess of 80% of the world’s supply of lithium. Dajin’s wholly owned Argentinian subsidiary, Dajin Resources S. A., has entered into an agreement with Lithium S Corporation (“Lithium S”) whereby Lithium S has been granted an option to earn a 51% interest in Dajin’s lithium properties in Argentina upon the payment of $1,000,000 (paid) and the expenditure of $2,000,000 on the property within 2 years from receipt of exploration permit.

    In addition, Lithium S has subscribed for 2,777,777 Units of Dajin Resources Corp. at $0.18 per unit with 2,777,777 non-transferable share purchase warrants attached exercisable at $0.25 per share within 2 years.

  • Goliath Resources Limited, ( TSX-V: GOT )

    Get Quote

    Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF)(FSE: B4IE) is a precious metals project generator focused in the prolific Golden Triangle and surrounding area of northwestern British Columbia. It controls four highly prospective properties that include Bingo, Golddigger, Lucky Strike and Copperhead covering over 52,000 hectares.

    All four properties have returned widespread mineralization of high grade Gold, Silver and/or Copper numbers from exposed bedrock in situ at surface. The new Lorne Creek Au-Cu-Mo Porphyry and Gold Source discoveries at the Lucky Strike property are scheduled to have their inaugural drill program in July 2019.

    Goliath Resources Limited, ( TSX-V: GOT )

    Get Quote

    Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF)(FSE: B4IE) is a precious metals project generator focused in the prolific Golden Triangle and surrounding area of northwestern British Columbia. It controls four highly prospective properties that include Bingo, Golddigger, Lucky Strike and Copperhead covering over 52,000 hectares.

    All four properties have returned widespread mineralization of high grade Gold, Silver and/or Copper numbers from exposed bedrock in situ at surface. The new Lorne Creek Au-Cu-Mo Porphyry and Gold Source discoveries at the Lucky Strike property are scheduled to have their inaugural drill program in July 2019.

  • Hempco Food and Fiber Inc., ( TSX.V:HEMP )

    Get Quote

    Hempco Food and Fiber Inc., formerly Genview Capital Corp., is a Canada-based company, which provides hemp seed foods for humans and animals. The Company is engaged in hemp seed food research and development, manufacturing, distribution and marketing. The Company’s products include Hemp Protein Powder, Hemp Seed Oil and Hulled Hemp Seed Nut. The Company’s Hemp Protein Powder is the protein source for humans, which consists of edestin and albumin. The Company’s Hemp Seed Oil can be added to salads, shakes, smoothies and other cooked or raw food recipes. The Company’s Hulled Hemp Seed is a one-seeded fruit or Achene and is available in approximately 50 pound (lb) poly lined paper bags and approximately 2,000 lb poly lined super totes. The Hulled Hemp Seed can be added to shakes, smoothies, salad dressing, sauces and baking. The Company produces a range of hemp-based foods, snacks and oil under the brand name, PlanetHemp. It has not generated revenues from operations.

    Hempco Food and Fiber Inc., ( TSX.V:HEMP )

    Get Quote

    Hempco Food and Fiber Inc., formerly Genview Capital Corp., is a Canada-based company, which provides hemp seed foods for humans and animals. The Company is engaged in hemp seed food research and development, manufacturing, distribution and marketing. The Company’s products include Hemp Protein Powder, Hemp Seed Oil and Hulled Hemp Seed Nut. The Company’s Hemp Protein Powder is the protein source for humans, which consists of edestin and albumin. The Company’s Hemp Seed Oil can be added to salads, shakes, smoothies and other cooked or raw food recipes. The Company’s Hulled Hemp Seed is a one-seeded fruit or Achene and is available in approximately 50 pound (lb) poly lined paper bags and approximately 2,000 lb poly lined super totes. The Hulled Hemp Seed can be added to shakes, smoothies, salad dressing, sauces and baking. The Company produces a range of hemp-based foods, snacks and oil under the brand name, PlanetHemp. It has not generated revenues from operations.

  • Invictus MD, ( CNSX:IMH )

    Get Quote

    Invictus MD targets small and mid size companies with proven brands, strong customer focus, and significant growth potential. The MD in our name stands for Managing Director. We direct the strategy towards profitability and growth for each of our portfolio companies. We assist the companies with business process integration and by structuring and deploying proper capital to support sustained growth.

    Invictus MD, ( CNSX:IMH )

    Get Quote

    Invictus MD targets small and mid size companies with proven brands, strong customer focus, and significant growth potential. The MD in our name stands for Managing Director. We direct the strategy towards profitability and growth for each of our portfolio companies. We assist the companies with business process integration and by structuring and deploying proper capital to support sustained growth.

  • Next Group Holdings Inc, ( OTCMKTS:PLKD )

    Get Quote

    Next Group Holdings Inc is a technology company which focuses on offering enhanced mobility solutions to the unbanked, under-served, and emerging markets. The company primarily operates through its subsidiaries: NEXT | CALA, a general purpose reloadable Visa Card, NXT | GN, a provider of a multipoint HD video platform and NEXT | MOBILE360, a provider of mobile voice, text, and data services. The company’s mission is to enable a mobile lifestyle for everyone by providing a 360 integrated mobile experience and mobile banking solution. NGH operates under the slogan “ Live your mobile lifestyle.”.

    Next Group Holdings Inc, ( OTCMKTS:PLKD )

    Get Quote

    Next Group Holdings Inc is a technology company which focuses on offering enhanced mobility solutions to the unbanked, under-served, and emerging markets. The company primarily operates through its subsidiaries: NEXT | CALA, a general purpose reloadable Visa Card, NXT | GN, a provider of a multipoint HD video platform and NEXT | MOBILE360, a provider of mobile voice, text, and data services. The company’s mission is to enable a mobile lifestyle for everyone by providing a 360 integrated mobile experience and mobile banking solution. NGH operates under the slogan “ Live your mobile lifestyle.”.

  • North American Cannabis Holdings, ( OTCMKTS:USMJ )

    Get Quote

    North American Cannabis Holdings, Inc. (USMJ) is founded on the core belief that cannabis makes people’s lives better.  Cannabis can fight disease, improve wellness and do so in an environmentally sustainable manner.  North American Cannabis Holdings is dedicated to developing the best possible applications for cannabis to serve consumers. Over time, the Company anticipates introducing additional subsidiaries dedicated to the various pilot initiatives coming out of American Seed & Oil Company that gain traction similar to the cannabis infused beverage pilot.

    North American Cannabis Holdings, ( OTCMKTS:USMJ )

    Get Quote

    North American Cannabis Holdings, Inc. (USMJ) is founded on the core belief that cannabis makes people’s lives better.  Cannabis can fight disease, improve wellness and do so in an environmentally sustainable manner.  North American Cannabis Holdings is dedicated to developing the best possible applications for cannabis to serve consumers. Over time, the Company anticipates introducing additional subsidiaries dedicated to the various pilot initiatives coming out of American Seed & Oil Company that gain traction similar to the cannabis infused beverage pilot.

Latest Stock News

Latest news from the stock market.

Immunoprecise proposes use of PolyTope to treat virus

2020-03-12 07:38 ET - News Release

Dr. Jennifer Bath reports

IMMUNOPRECISE ANNOUNCES THE LAUNCH OF POLYTOPE MAB THERAPY(TM) TO TACKLE CORONAVIRUS PANDEMIC

Following its announcement to develop innovative treatments against the new coronavirus, SARS-CoV-2, Immunoprecise Antibodies Ltd. has unveiled its unique approach utilizing PolyTope mAb Therapy, enabled by its diverse discovery platforms and artificial intelligence capabilities with its partner, EVQLV Inc., in the development of a universal COVID-19 therapy.

Current vaccine strategies under development for SARS-CoV-2 are being designed to protect uninfected individuals, however, this does not address the patients with active disease. Antibody therapies represent a potentially powerful treatment option for COVID-19 patients, however, the current, proposed curative options (including polyclonal, sensitized serum or individual monoclonal antibody therapies) are potentially susceptible to escape by viral mutation and are likely not broadly effective against multiple strains, leaving segments of the population untreatable.

"Given the continuous increase in information on SARS-CoV-2 transmission, and seemingly higher than predicted mutation rates, we believe that traditional treatments and diagnostics targeting limited epitopes may present a significant liability for long-term efficacy of a therapeutic, vaccine or diagnostic," stated Immunoprecise chief executive officer and president Dr. Jennifer Bath.

The emerging SARS-CoV-2 virus, and other new (related) pathogens, requires the rapid development of broadly effective treatments and vaccines. Given its biology, developing an effective therapeutic work plan for treating SARS-CoV-2 infection required a sophisticated approach that considered multiple mechanisms of immune system involvement, the predictability of mutations within the virus genome, and other attributes with the potential to provide maximum clinical benefit for both current and future variants of the virus.

Ilse Roodink, chairwoman of Talem's scientific advisory committee and coronavirus global project leader, emphasized, "Our PolyTope mAb Therapy perfectly combines the benefits of using well-defined and fully characterized monoclonal antibodies with the essential need for a multitargeting strategy to tackle this quickly emerging virus, thereby significantly accelerating effective clinical application."

About Immunoprecise Antibodies Ltd.

Immunoprecise is a full-service, therapeutic antibody discovery contract research organization offering species agnostic, multiformat, characterized and engineered, human monoclonal antibodies, on an abbreviated time frame, for its pharmaceutical clients. There is no assurance that Immunoprecise will be successful in the development of a vaccine and/or therapeutic against the new coronavirus.

  • HOME

© 2025 OTCWagon. All Rights Reserved. 2015 - 2025